Thyroid Cancer | CHOP Research Institute
 

Thyroid Cancer

The Bauer Lab focuses on improving our understanding of the molecular landscape of pediatric thyroid cancer in an effort to optimize the diagnostic accuracy of fine needle aspiration, identify markers that predict invasive behavior and prognosis, and identify targets for improved treatment options.

This study enrolls patients with newly diagnosed differentiated thyroid cancer (papillary thyroid cancer or follicular thyroid cancer) that has spread to the lungs and has a genetic mutation called and NTRK fusion.

This study involves taking a study drug called selpercatinib.

Published on
Jan 27, 2023
By studying the molecular basis of pediatric thyroid cancer, Dr. Franco seeks to improve outcomes and quality of life for patients.

The Child and Adolescent Thyroid Consortium (CATC) Biorepository is a collaborative research program dedicated to studying thyroid cancers and other thyroid-related conditions.

Published on
Jan 28, 2021
The Thyroid Center at CHOP recently earned Frontier Status, allowing it to research the many unanswered questions about pediatric thyroid cancer.

Dr. Franco researches the molecular basis of the differences between pediatric and adult onset thyroid cancer. She aims to understand how the tumor microenvironment impacts disease progression and response to therapy.

E-mail:
francoa1 [at] chop.edu
Published on
Jul 17, 2020
This week’s In the News roundup features research on home nursing, COVID-19, telehealth, and thyroid cancer.

Dr. Bauer's academic and clinical career are focused on improving the care of children and adolescents with thyroid disease. He has extensive experience and knowledge of thyroid pathophysiology and tumorigenesis, and has been critical to the clinical success of the Children's Hospital of Philadelphia Thyroid Center.

E-mail:
bauera [at] chop.edu